These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3954945)

  • 1. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1984 Jul; 50(1):77-83. PubMed ID: 6743517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of MeCCNU-resistance in clonally derived lines of Lewis lung carcinoma.
    McMillan TJ; Stephens TC; Peacock JH; Steel GG
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):801-5. PubMed ID: 3653197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy.
    Stephens TC; Adams K; Peacock JH; Steel GG
    Radiother Oncol; 1986 Feb; 5(2):137-46. PubMed ID: 3704188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of two mouse tumours to hyperthermia with CCNU or melphalan.
    Joiner MC; Steel GG; Stephens TC
    Br J Cancer; 1982 Jan; 45(1):17-26. PubMed ID: 7059461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA; Otter GM; Chen CF
    Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrosoureas as single agents in the treatment of pulmonary cancer.
    Wolf J
    Cancer Treat Rep; 1976 Jun; 60(6):753-6. PubMed ID: 782697
    [No Abstract]   [Full Text] [Related]  

  • 12. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure rates and tumor resistance in cured mice after nitrosourea treatment of EMT6 ascites tumors.
    Feola JM; Maruyama Y
    Oncology; 1986; 43(6):372-7. PubMed ID: 2949185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential action of liposome-entrapped 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on lung metastasis of Lewis lung carcinoma as compared with the free drug.
    Inaba M; Yoshida N; Tsukagoshi S
    Gan; 1981 Jun; 72(3):341-5. PubMed ID: 7319193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.
    Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
    Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of BCNU, CCNU and MeCCNU in the prevention of the development of tumors of the nervous system.
    Pezzotta S; Agradi E; Paoletti P
    Pharmacol Res Commun; 1975 Feb; 07(1):49-53. PubMed ID: 1153462
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical comparison of the nitrosoureas.
    Wasserman TH; Slavik M; Carter SK
    Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.